ARTICLE
|
doi:10.20944/preprints202109.0156.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
circulating thymidine kinase 1; cell loss; biomarker; early treatment response; breast cancer
Online: 8 September 2021 (16:25:39 CEST)